Dr. Joseph A Samady , MD
Dermatology • Oceanside, CA
3629 Vista Way
Oceanside, CA 920564522
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on June 1, 2006; this date does not establish years in practice.
-
Published CMS data list 7,571 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 17003 — Destruction of precancer skin growth, 2-14 growths: 2,902 service units.
- 99213 — Established patient outpatient office visit: 1,705 service units.
- 17000 — Destruction of precancer skin growth, 1 growth: 1,056 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 21 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,436 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Hydrocortisone — 202 prescription fills, including refills.
- Fluorouracil — 168 prescription fills, including refills.
- Fluocinonide — 156 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 24 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 85% of clinicians listed under Dermatology in California (2024, 1,168 clinicians with data). Median for this group: 2,239. Middle half: 927 to 4,781.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 6,500 in 2020 to 7,571 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
3629 Vista Way
Oceanside, CA 920564522
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 2 distinct additional practice-address records in Fallbrook, CA; San Diego, CA. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Dermatology Specialists Inc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Rutgers New Jersey Medical School
1996
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,455 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $512,316 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $351,941 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
1,568 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$676,912 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,476.64 across 66 records.
By nature of payment
- Food and Beverage: $1,277.65 across 64 records.
- Education: $198.99 across 2 records.
Reporting-company totals (3 largest of 15)
- Janssen Pharmaceuticals, Inc: $314.09 across 9 records.
- LEO Pharma Inc.: $205.92 across 9 records.
- Galderma Laboratories, L.P.: $199.12 across 10 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
30 years (graduated 1996)
CMS Doctors and Clinicians data list 1996 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Samady has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Samady as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Oceanside and California
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 85% of clinicians listed under Dermatology in California (2024, 1,168 clinicians with data). Median for this group: 2,239. Middle half: 927 to 4,781.
Too few clinicians listed under Dermatology in Oceanside have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 80% of clinicians listed under Dermatology in California (2024, 1,168 clinicians with data). Median for this group: $174,429. Middle half: $66,277 to $372,447.
Too few clinicians listed under Dermatology in Oceanside have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 80% of clinicians listed under Dermatology in California (2024, 1,168 clinicians with data). Median for this group: $125,261. Middle half: $46,635 to $274,791.
Too few clinicians listed under Dermatology in Oceanside have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Dermatology in Oceanside, CA (2024, 13 clinicians with data). Median for this group: 708. Middle half: 209 to 935.
More Part D prescriptions than 90% of clinicians listed under Dermatology in California (2024, 1,474 clinicians with data). Median for this group: 461. Middle half: 180 to 904.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Dermatology in Oceanside, CA (2024, 13 clinicians with data). Median for this group: $54,605. Middle half: $4,773 to $214,754.
A higher Part D drug cost than 90% of clinicians listed under Dermatology in California (2024, 1,474 clinicians with data). Median for this group: $65,584. Middle half: $5,909 to $248,782.
17 active clinicians are listed under Dermatology with a practice address in Oceanside, CA (2,084 in California).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Oceanside
11.8% of these 17 clinicians have the CMS telehealth indicator.
70.6% of these 17 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 16% from 6,500 in 2020 to 7,571 in 2024.
- 2020: 6,500
- 2021: 7,608
- 2022: 6,798
- 2023: 7,214
- 2024: 7,571
-
Medicare-allowed amount
Medicare-allowed amount increased 21% from $423,739 in 2020 to $512,316 in 2024.
- 2020: $423,739
- 2021: $531,883
- 2022: $478,980
- 2023: $488,101
- 2024: $512,316
-
Paid by Medicare
Paid by Medicare increased 19% from $296,333 in 2020 to $351,941 in 2024.
- 2020: $296,333
- 2021: $374,706
- 2022: $331,393
- 2023: $338,796
- 2024: $351,941
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 73% from 831 in 2020 to 1,436 in 2024.
- 2020: 831
- 2021: 958
- 2022: 839
- 2023: 972
- 2024: 1,436
-
30-day fills
30-day fills increased 81% from 865 in 2020 to 1,568 in 2024.
- 2020: 865
- 2021: 978
- 2022: 860
- 2023: 1,018
- 2024: 1,568
-
Part D drug cost
Part D drug cost increased 557% from $103,043 in 2020 to $676,912 in 2024.
- 2020: $103,043
- 2021: $107,580
- 2022: $184,263
- 2023: $248,321
- 2024: $676,912
-
Industry payments (Open Payments)
Industry payments (Open Payments) varied from year to year: $1,491.69 in 2021 and $1,476.64 in 2025.
- 2021: $1,491.69
- 2022: $1,688.08
- 2023: $1,629.56
- 2024: $1,992.86
- 2025: $1,476.64
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 66 records totaling $1,476.64.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Journey Medical Corporation |
Food and Beverage
In-kind items and services
|
— | General | $116.86 |
| Galderma Laboratories, L.P. |
Food and Beverage
In-kind items and services
|
NEMLUVIO | General | $103.84 |
| Janssen Pharmaceuticals, Inc |
Education
In-kind items and services
|
TREMFYA | General | $99.99 |
| Janssen Pharmaceuticals, Inc |
Education
In-kind items and services
|
TREMFYA | General | $99.00 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ANZUPGO | General | $52.45 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $40.60 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $32.13 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $32.04 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $29.51 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $29.15 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
LIBTAYO | General | $29.15 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $28.28 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $28.27 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $27.68 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $27.28 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $26.97 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
TALTZ | General | $24.99 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $24.20 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $24.00 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $22.33 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $22.13 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $22.04 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
CIBINQO | General | $22.03 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
COSENTYX | General | $20.47 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $20.06 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
17003
Destruction of precancer skin growth, 2-14 growths
|
2,902 | 585 | $8.26 | $7.74 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
1,705 | 1,097 | $107.42 | $99.43 |
|
17000
Destruction of precancer skin growth, 1 growth
|
1,056 | 770 | $82.29 | $64.04 |
|
11102
Biopsy of related skin growth, first growth
|
415 | 361 | $123.89 | $107.50 |
|
17110
Destruction of skin growth, 1-14 growths
|
353 | 309 | $140.65 | $129.59 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
314 | 314 | $130.09 | $120.87 |
|
88305
Pathology examination of tissue using a microscope, intermediate complexity
|
242 | 158 | $85.91 | $81.21 |
|
11103
Biopsy of related skin growth, each additional growth
|
126 | 85 | $61.99 | $57.26 |
|
17262
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
|
86 | 68 | $210.99 | $184.06 |
|
J7308
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
|
84 | 61 | $432.31 | $389.66 |
|
96574
Application of light with debridement to destroy precancer skin growth
|
58 | 50 | $351.08 | $325.98 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
56 | 51 | $69.90 | $62.67 |
|
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
32 | 13 | $1.04 | $0.97 |
|
12032
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm
|
26 | 24 | $367.50 | $337.73 |
|
17004
Destruction of precancer skin growth, 15 or more growths
|
24 | 22 | $228.09 | $189.43 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
18 | 17 | $156.61 | $140.07 |
|
69100
Biopsy of ear
|
17 | 17 | $116.90 | $85.73 |
|
11602
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm
|
15 | 13 | $298.73 | $137.68 |
|
11900
Injection into skin growth, 1-7 growths
|
15 | 11 | $67.46 | $56.14 |
|
12031
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less
|
14 | 12 | $325.02 | $297.88 |
|
96567
Application of light to destroy precancer skin growth
|
13 | 13 | $179.43 | $163.81 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Hydrocortisone | Hydrocortisone | 202 | 4,665 | $832.54 | 181 |
| Fluorouracil | Fluorouracil | 168 | 5,062 | $10,994.71 | 157 |
| Fluocinonide | Fluocinonide | 156 | 4,092 | $4,146.89 | 106 |
| Doxycycline Hyclate | Doxycycline Hyclate | 111 | 4,546 | $2,640.39 | 33 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 110 | 2,654 | $580.56 | 87 |
| Ketoconazole | Ketoconazole | 107 | 3,240 | $2,042.48 | 64 |
| Clobetasol Propionate | Clobetasol Propionate | 95 | 2,818 | $6,131.22 | 56 |
| Imiquimod | Imiquimod | 74 | 2,230 | $2,190.71 | 60 |
| Mupirocin | Mupirocin | 73 | 1,666 | $447.80 | 60 |
| Hydrocortisone Valerate | Hydrocortisone Valerate | 53 | 1,263 | $1,148.45 | 40 |
| Clindamycin Phosphate | Clindamycin Phosphate | 48 | 1,700 | $1,387.03 | 23 |
| Metronidazole | Metronidazole | 35 | 1,030 | $1,649.59 | 23 |
| Dupixent Pen | Dupilumab | 33 | 896 | $122,915.49 | — |
| Valacyclovir | Valacyclovir Hcl | 26 | 544 | $506.64 | 20 |
| Tacrolimus | Tacrolimus | 23 | 690 | $1,854.90 | 14 |
| Adbry | Tralokinumab-Ldrm | 16 | 448 | $59,651.45 | — |
| Zoryve | Roflumilast | 16 | 480 | $13,180.32 | — |
| Prednisone | Prednisone | 15 | 331 | $27.45 | — |
| Tretinoin | Tretinoin | 13 | 380 | $596.44 | — |
| Otezla | Apremilast | 13 | 390 | $66,898.88 | — |
| Pimecrolimus | Pimecrolimus | 13 | 381 | $2,042.35 | 11 |
| Minoxidil | Minoxidil | 12 | 640 | $61.72 | — |
| Stelara | Ustekinumab | 12 | 1,026 | $212,895.07 | — |
| Humira(Cf) Pen | Adalimumab | 12 | 336 | $162,089.28 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2020-02-10NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - DERMATOLOGY
I20060606000191
CA
9739190802
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Dermatology Specialists Inc
1309 S Mission Rd A, Fallbrook, CA 920284168
Phone: 7607287546
Secondary Practice Locations
4765 Carmel Mountain Rd Ste 201
San Diego, CA 921306657
Phone: 8583697546
1309 S Mission Rd Ste A
Fallbrook, CA 920284168
Phone: 7607287546
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Physician Assistant
Physician Assistant
Dermatology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated June 01, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Dermatology Specialists in Oceanside
- Dr. Alina Goldenberg, MD
- Dimitri De Kouchkovsky, MD-PHD
- Kunal Angra
- Dr. Arun Venkat, MD
- Dr. Jens Thiele, MD
- Dr. Ronnie Youssef, MD
More public profiles in California
Directory navigation, in NPI number order.
- Vincent Lee, MD Radiology - Radiation Oncology · Sacramento
- Sheri Feldman, MD Dermatology · Beverly Hills
- Monica Tong, DDS Dentist · San Francisco
- Frank Gilman, MD Internal Medicine · San Diego
- Shira Miller, MD Internal Medicine · Newport Beach
- Blake Ashley, MD Surgery · Laguna Hills
- Erik Ekizian, DC Chiropractor · Merced
- Christianne Transfiguracion Shin Podiatrist · Murrieta
- Ravinder Singh, DDS Dentist - General Practice · Long Beach
- Hien Truong, MD Pediatrics · San Jose
- Moises Carpio, MD, FCCP, CHCQM Internal Medicine - Critical Care Medicine · San Diego
- Harold Ascherman, PA-C Nurse Practitioner · Redding
Mailing Address
3629 Vista Way
Oceanside, CA 920564522
Phone: 7608289200